Back to top

Myriad Genetics Inc: (NASD: MYGN)

(U.S: NASD) As of Apr 17, 2014 03:59 PM ET

 Add to portfolio

 ZacksTrade Now

$37.97 USD

-0.36 (-0.94%)

Volume: 2,095,294

Zacks Rank : 1-Strong Buy [?] 1        

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.94%
2 Buy 19.04%
3 Hold 10.56%
4 Sell 4.8%
5 Strong Sell 2.59%
S&P 500 10.39%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Financial Overview

Fundamental Ratios

P/E
P/E (F1) 17.31
Trailing 12 Months 16.45
PEG Ratio 1.19
EPS Growth
vs. Previous Year 57.14%
vs. Previous Quarter -2.94%
   
Sales Growth
vs. Previous Year 36.82%
vs. Previous Quarter 0.79%
   
Price Ratios
Price/Book 4.24
Price/Cash Flow 19.57
Price / Sales 3.79
ROE
3/31/14 NA
12/31/13 27.22
9/30/13 25.12
ROA
3/31/14 NA
12/31/13 24.46
9/30/13 22.75
Current Ratio
3/31/14 NA
12/31/13 6.74
9/30/13 5.80
Quick Ratio
3/31/14 NA
12/31/13 6.74
9/30/13 5.80
Operating Margin
3/31/14 NA
12/31/13 25.48
9/30/13 25.28
Net Margin
3/31/14 NA
12/31/13 25.48
9/30/13 25.28
Pre-Tax Margin
3/31/14 NA
12/31/13 39.94
9/30/13 39.18
Book Value
3/31/14 NA
12/31/13 9.04
9/30/13 8.58
Inventory Turnover
3/31/14 NA
12/31/13 31.00
9/30/13 15.54
Debt-to-Equity
3/31/14 NA
12/31/13 0.00
9/30/13 0.00
Debt to Capital
3/31/14 NA
12/31/13 0.00
9/30/13 0.00
 

MYGN Chart by YCharts